Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 21;6(1):e668.
doi: 10.1097/HS9.0000000000000668. eCollection 2022 Jan.

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

Affiliations

High Prevalence of Constitutional Mismatch Repair Deficiency in a Pediatric T-cell Lymphoblastic Lymphoma Cohort

Emma Kroeze et al. Hemasphere. .

Abstract

This study describes the clinical characteristics of a complete Dutch T-cell lymphoblastic lymphoma (T-LBL) cohort, including second primary malignancies and comorbidities. We show that over 10% of patients in this complete T-LBL cohort have been diagnosed with a cancer predisposition syndrome (CPS), consisting almost exclusively of constitutional mismatch repair deficiency (CMMRD). The clinical characteristics of sporadic T-LBL patients were compared with T-LBL patients that have been diagnosed with CMMRD. This shows that disease presentation is comparable but that disease localization in CMMRD patients might be more localized. The percentage of CPS seems reliable considering the completeness of the cohort of Dutch T-LBL patients and might even be an underestimation (possibility of undiagnosed CPS patients in cohort). As the frequency of an underlying predisposition syndrome among T-LBL patients may be underestimated at present, we advocate for screening all pediatric T-LBL patients for the presence of germline mutations in mismatch repair genes.

PubMed Disclaimer

References

    1. Swerdlow SH, Campo E, Lee Harris N, et al. . WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th ed.) (World Health Organization Classification of Tumours). Lyon, France: International Agency for Research on Cancer (IARC); 2017.
    1. Landmann E, Burkhardt B, Zimmermann M, et al. . Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma. Haematologica. 2017;102:2086–2096. - PMC - PubMed
    1. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin’s lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:332–339. - PubMed
    1. Rosolen A, Perkins SL, Pinkerton CR, et al. . Revised international pediatric non-Hodgkin lymphoma staging system. J Clin Oncol. 2015;33:2112–2118. - PMC - PubMed
    1. Kroeze E, Loeffen JLC, Poort VM, et al. . T-cell lymphoblastic lymphoma and leukemia: different diseases from a common premalignant progenitor? Blood Adv. 2020;4:3466–3473. - PMC - PubMed